{"pmid":32442555,"title":"TYPE 1 DIABETES TRIGGERED BY COVID-19 PANDEMIC: A POTENTIAL OUTBREAK?","text":["TYPE 1 DIABETES TRIGGERED BY COVID-19 PANDEMIC: A POTENTIAL OUTBREAK?","Diabetes Res Clin Pract","Caruso, Paola","Longo, Miriam","Esposito, Katherine","Ida Maiorino, Maria","32442555"],"journal":"Diabetes Res Clin Pract","authors":["Caruso, Paola","Longo, Miriam","Esposito, Katherine","Ida Maiorino, Maria"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442555","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.diabres.2020.108219","keywords":["covid-19","sars-cov-2","autoimmune pathogenesis","type 1 diabetes"],"topics":["Mechanism"],"weight":1,"_version_":1667535119505686528,"score":9.490897,"similar":[{"pmid":32429702,"title":"Telemedicine Consultations and Diabetes Technology During COVID-19.","text":["Telemedicine Consultations and Diabetes Technology During COVID-19.","J Diabetes Sci Technol","Norgaard, Kirsten","32429702"],"journal":"J Diabetes Sci Technol","authors":["Norgaard, Kirsten"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429702","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929378","keywords":["cgm","covid-19","insulin pumps","telemedicine consultations","type 1 diabetes","uploading programs"],"topics":["Prevention"],"weight":1,"_version_":1667342288160817152,"score":62.082314},{"pmid":32315948,"pmcid":"PMC7153521","title":"Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","text":["Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery.","Diabetes Metab Syndr","Baretic, Maja","32315948"],"abstract":["A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery."],"journal":"Diabetes Metab Syndr","authors":["Baretic, Maja"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315948","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.dsx.2020.04.014","keywords":["chloroquine","hypoglycaemia","remission","type 1 diabetes"],"e_drugs":["Chloroquine"],"topics":["Prevention"],"weight":1,"_version_":1666138493563174913,"score":60.85249},{"pmid":32443962,"title":"How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","text":["How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","J Diabetes Sci Technol","Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew","32443962"],"journal":"J Diabetes Sci Technol","authors":["Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443962","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929368","keywords":["covid-19","continuous glucose monitoring","novel coronavirus","type 1 diabetes","type 2 diabetes"],"topics":["Prevention"],"weight":1,"_version_":1667600475791294464,"score":58.511734},{"pmid":32502296,"title":"SARS-CoV2 as a potential trigger of neurodegenerative diseases.","text":["SARS-CoV2 as a potential trigger of neurodegenerative diseases.","Mov Disord","Gomez-Pinedo, Ulises","Matias-Guiu, Jorge","Sanclemente-Alaman, Inmaculada","Moreno-Jimenez, Lidia","Montero-Escribano, Paloma","32502296"],"journal":"Mov Disord","authors":["Gomez-Pinedo, Ulises","Matias-Guiu, Jorge","Sanclemente-Alaman, Inmaculada","Moreno-Jimenez, Lidia","Montero-Escribano, Paloma"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502296","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/mds.28179","keywords":["ace2 receptor","alzheimer's disease","covid-19","parkinson's disease","sars-cov2","neurodegenerative diseases"],"topics":["Mechanism"],"weight":1,"_version_":1668804508949413888,"score":50.64553}]}